SIGA
Siga Technologies Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Siga Technologies has 9 disclosed suppliers and 5 disclosed customers in SEC filings.
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−2.24%
vs ±27.9% implied · ×0.08
shaded = implied · ▲▼ = realized
Siga Technologies Inc
3.01
SentenceSIGA has had manufacturing agreements with Grace and a predecessor owner (Albemarle) since 2011.
SIGA 10-Kaccession 0001437749-26-007557
SentenceAs such, until June 28, 2027, SIGA will purchase all of its requirements for bulk product for oral TPOXX® under the 19C BARDA Contract from Catalent.
SIGA 10-Kaccession 0001437749-26-007557
SentenceUnder the terms of the Amended International Promotion Agreement, Meridian remains responsible for collecting payments from customers under certain legacy contracts and remitting such payments to us on a quarterly basis.
SIGA 10-Kaccession 0001437749-26-007557
SentenceMicrosize micronizes and tests API for use in oral TPOXX®.
SIGA 10-Kaccession 0001437749-26-007557
SentencePCI provides packaging services in connection with oral TPOXX®.
SIGA 10-Kaccession 0001437749-26-007557
SentenceSIGA agreed that Patheon was entitled to manufacture at least 80% of IV TPOXX® offered for sale by SIGA during the first three years of the agreement, provided Patheon adhered to reasonable manufacturing standards.
SIGA 10-Kaccession 0001437749-26-007557
SentenceRoquette provides an excipient used in the manufacturing of IV TPOXX®.
SIGA 10-Kaccession 0001437749-26-007557
SentenceBecause samples from that trial are being reanalyzed by the U.S. Centers for Disease Control and Prevention which has been impacted by recent U.S. Government shutdowns, the Company is now targeting a supplemental NDA submission within the next twelve months.
SIGA 10-Kaccession 0001437749-26-007557
SentenceAs of December 31, 2025, SIGA has purchased more than 12 metric tons of API; as such, SIGA will purchase at least 70% of its internal and external API requirements for TPOXX® from Grace until the end of the term of the agreement (as described below), unless the Company receives an offer to purchase API at a price that Grace is unable to match, in which event SIGA will purchase at least 30% of its internal and external API requirements for TPOXX® from Grace until the Company has fulfilled its delivery obligations under the 19C BARDA Contract.
SIGA 10-Kaccession 0001437749-26-007557
SentenceFor international sales in the first and second quarters, Meridian Medical Technologies ("Meridian") was the counterparty to contracts under which the sales were made (see discussion and definition below regarding International Promotion Agreement).
SIGA 10-Kaccession 0001437749-26-007557
SentenceOn September 10, 2018, the Company entered into a contract with the U.S. Biomedical Advanced Research and Development Authority ("BARDA") pursuant to which SIGA agreed to deliver up to 1,488,000 courses of oral TPOXX® to the Strategic Stockpile, and to manufacture and deliver to the Strategic Stockpile, or store as vendor-managed inventory, up to 212,000 courses of IV TPOXX®.
SIGA 10-Kaccession 0001437749-26-007557
SentenceIn 2024, the Company had sales of approximately $10 million with the U.S. Department of Defense ("DoD") (also known as the Department of War).
SIGA 10-Kaccession 0001437749-26-007557
SentenceWe expect a substantial percentage of our future operating revenues to come from contracts with the U.S. Government for the provision and maintenance of the stockpile of TPOXX® built under the 19C BARDA Contract.
SIGA 10-Kaccession 0001437749-26-007557
SentenceThe Company has been delivering oral TPOXX® to the U.S. Strategic National Stockpile ("Strategic Stockpile") since 2013.
SIGA 10-Kaccession 0001437749-26-007557
Largest filed tie
—
Expected move
No implied move.